Detalles de la búsqueda
1.
Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor.
Int J Mol Sci
; 25(1)2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203787
2.
Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.
Anticancer Drugs
; 33(10): e842-e849, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206101
3.
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma.
Medicina (Kaunas)
; 58(7)2022 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35888627
4.
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment.
Oncology
; 99(1): 32-40, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32894845
5.
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients.
Anticancer Drugs
; 32(10): 1099-1104, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232936
6.
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study.
J Formos Med Assoc
; 120(2): 874-882, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891489
7.
EGFR mutation and lobar location of lung adenocarcinoma.
Carcinogenesis
; 37(2): 157-162, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26645716
8.
Expression of a gene encoding a rice RING zinc-finger protein, OsRZFP34, enhances stomata opening.
Plant Mol Biol
; 86(1-2): 125-37, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25002225
9.
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib.
Ther Adv Med Oncol
; 16: 17588359231220606, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38188463
10.
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
Lancet Respir Med
; 12(2): 141-152, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042167
11.
EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients.
Int J Cancer
; 132(2): 449-58, 2013 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22573488
12.
Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways.
Mol Carcinog
; 52(3): 183-94, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22086658
13.
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
J Formos Med Assoc
; 112(1): 31-40, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332427
14.
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib.
Onco Targets Ther
; 16: 317-326, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220494
15.
Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy.
Cancer Manag Res
; 15: 1251-1262, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37953889
16.
Rice OsHsp16.9A interacts with OsHsp101 to confer thermotolerance.
Plant Sci
; 330: 111634, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36775071
17.
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
Front Oncol
; 13: 1096683, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36925928
18.
Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
J Thorac Oncol
; 18(11): 1492-1503, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414358
19.
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients.
Sci Rep
; 12(1): 9753, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35697720
20.
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan.
Target Oncol
; 17(3): 295-306, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460474